Copyright
©The Author(s) 2024.
World J Stem Cells. Sep 26, 2024; 16(9): 846-853
Published online Sep 26, 2024. doi: 10.4252/wjsc.v16.i9.846
Published online Sep 26, 2024. doi: 10.4252/wjsc.v16.i9.846
Ref. | Cell source | Secretome | Model | Disease | Function and mechanism |
Kang et al[24] | Human UC-MSC-EV | - | Mouse/HepG2 and AML12 cells | NASH | Nrf2/NQO-1 antioxidant signaling pathway |
Yang et al[25] | Human UC-MSC-EV | CAMKK1 | Mouse/hepatic cells | NAFLD | CAMKK1-mediated lipid homoeostasis regulation |
Chen et al[30] | MSC-sEV | RNF31 | Mouse | NAFLD | Regulation of mitochondrial homeostasis |
Du et al[26] | Human UC-MSC-Exo | MiRNA-24-3p | Mouse/hepatocytes | NAFLD | MiR-24-3p directly targeted Kelch-like ECH-associated protein 1, and suppressed its expression |
Restrained lipid accumulation, ROS generation, and inflammation | |||||
Niu et al[27] | AD-MSC-EV | MiRNA-223-3p | Mouse/hepatocytes | NAFLD | MiR-223-3p displayed suppressive effects on lipid accumulation and liver fibrosis through E2F1 inhibition |
Cheng et al[28] | Human UC-MSC-Exo | MiRNA-627-5p | Rat/L-02 cells | NAFLD | MiR-627-5p improved glucose and lipid metabolism and alleviated liver damage by repressing FTO expression |
El-Derany et al[29] | BM-MSC-Exo | MiRNA-96-5p | Mouse | NASH | Caspase-2 signaling inhibition |
Tawfeek and Kasem[20] | Curcumin-preconditioned MSC-Exo | - | Mouse/HepG2 cells | NASH | Regulated inflammatory, oxidative stress, and mitochondrial-dependent apoptosis-associated ASK-JNK-BAX genes |
Kim et al[21] | Pan-peroxisome proliferator-activated receptor agonist-primed induced MSC-EV | - | Mouse | NASH | Reduced steatotic changes and ameliorated ER stress and mitochondiral oxidative stress induced by inflammation |
Zhang et al[23] | MSC-sEV | - | Mouse | NASH | Polarized pro-fibrotic M2 macrophages without exacerbating liver fibrosis |
Yang et al[31] | MSCs conditional medium | - | Mouse/L-02 cells | NAFLD | Improved mitochondrial function and alleviated inflammation and apoptosis by regulating SIRT1 |
- Citation: Gao FQ, Zhu JQ, Feng XD. Innovative mesenchymal stem cell treatments for fatty liver disease. World J Stem Cells 2024; 16(9): 846-853
- URL: https://www.wjgnet.com/1948-0210/full/v16/i9/846.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v16.i9.846